The Lead Episode 22: A Discussion of Catheter Ablation of Atrial Fibrillation in Adult Congenital Heart Disease: Procedural Characteristics and Outcomes-The Lead Episode 22 Speaker Information

The Lead Episode 22 Speaker Information

Pdf Summary

In the discussion, the feasibility and effectiveness of catheter ablation for atrial fibrillation (AA) in patients with adult congenital heart disease (ACHD) is explored. The authors of the article gathered information from various contributors and disclosed potential conflicts of interest. The study found that catheter ablation can reduce symptoms and is feasible for patients with ACHD.<br /><br />The host of the discussion is Michael S. Lloyd, MD, FHRS from Emory University. The contributors for this discussion are Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P from UCLA Medical Center, and Natasja M. S. De Groot, MD, PhD from Erasmus University Medical Center.<br /><br />The article, published in Circulation: Arrhythmia and Electrophysiology, discusses the findings that catheter ablation is feasible and effective in reducing symptoms of atrial fibrillation in ACHD patients. However, recurrence of AA frequently requires repeat ablation.<br /><br />In terms of disclosures, Jeremy P. Moore has no conflicts of interest to declare. Natasja M. S. De Groot has received honoraria, and has had speaking and consulting arrangements with Biosense Webster. Michael S. Lloyd has received honoraria, and has had speaking and consulting arrangements with Medtronic, Baylis Medical Company, and Boston Scientific.<br /><br />Overall, the discussion provides insight into the feasibility and effectiveness of catheter ablation for atrial fibrillation in patients with adult congenital heart disease. The study highlights the need for repeat ablation in cases of recurrence.

Keywords

catheter ablation

atrial fibrillation

adult congenital heart disease

feasibility

effectiveness

symptoms reduction

recurrence

contributors

conflicts of interest

disclosures